Orphazyme gains as social media interest spikes

Strategic Partners A/S

12/08/2021 12:07

** U.S.-listed shares in Danish biotech company Orphazyme
 ORPH.O  up 3% to $3.26 premarket
    ** ORPH-related message volume nearly triples on
trading-focused social media site Stocktwits; fourth-most
discussed stock on site
    ** About 96% of Stocktwits posts related to ORPH reflect
positive sentiment 
    ** ORPH shares have surged about 44% over the past two days
with trading volumes topping 40 mln on Tuesday, compared with
its 25-DMA of 7.3 mln
    ** Shares of the company tumbled about 50% in June after
U.S. health regulators rejected its key drug candidate to treat
genetic disorder Niemann-Pick disease type C  urn:newsml:reuters.com:*:nL2N2O00CG
    ** Up to Wednesday's close, stock down 43.5% YTD 

 (Reporting by Dania Nadeem)